Sort
39,280 grants matching “leukemia”
The influence of proteostasis loss in aging hematopoietic stem cells on leukemia initiation
$357,057Robert A.j. Signer · University Of California, San Diego · U01 · FY2023 · CA
Biostatistics
$357,007Stephen L George · Duke University · P30 · FY2014 · CA
Projecdt 3 - Modulation of bone environment to enhance response of bone cancers
$356,975John F Dipersio · Washington University · U54 · FY2019 · CA
Hematopoietic Transplantation for AML
$356,940Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA
Defining the determinants of response and resistance to therapy for Richter's Syndrome
$356,911Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2023 · CA
Acute Lymphoblastic Leukemia
$356,892Mary V. Relling · University Of Chicago · U01 · FY2006 · GM
Acute Lymphoblastic Leukemia
$356,892University Of Chicago · U01 · FY2005 · GM
Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis
$356,888Archibald S Perkins · University Of Rochester · R01 · FY2016 · CA
Targeting Cdc42 for bone marrow transplant therapies
$356,850Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · CA
Integration of epigenetic and non-coding RNA mechanisms in leukemia
$356,850Sara E Meyer · Thomas Jefferson University · R37 · FY2020 · CA
Novel Topoisomerase II alpha isoform as a drug resistance determinant
$356,850Jack C. Yalowich · Ohio State University · R01 · FY2021 · CA
Targeting Cdc42 for bone marrow transplant therapies
$356,850Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2015 · CA
Guidelines for processing and storing liquid biopsy samples for functional assays in research and clinical testing.
$356,850Tothu Q Vu · Oregon Health & Science University · U01 · FY2024 · CA
Integration of epigenetic and non-coding RNA mechanisms in leukemia
$356,850Sara E Meyer · Thomas Jefferson University · R37 · FY2022 · CA
Elucidation of Human Natural Killer Cell Development
$356,850Aharon G Freud · Ohio State University · R01 · FY2021 · CA
Novel Topoisomerase II alpha isoform as a drug resistance determinant
$356,850Jack C. Yalowich · Ohio State University · R01 · FY2020 · CA
Targeting Cdc42 for bone marrow transplant therapies
$356,850Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · CA
Biology and Targeting of noncoding RNAs in AML
$356,850Ramiro Garzon · Ohio State University · R01 · FY2020 · CA
Elucidation of Human Natural Killer Cell Development
$356,850Aharon G Freud · Ohio State University · R01 · FY2020 · CA
Targeting Cdc42 for bone marrow transplant therapies
$356,850Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2018 · CA
Integration of epigenetic and non-coding RNA mechanisms in leukemia
$356,850Sara E Meyer · Thomas Jefferson University · R37 · FY2021 · CA
Integration of epigenetic and non-coding RNA mechanisms in leukemia
$356,850Sara E Meyer · Thomas Jefferson University · R37 · FY2018 · CA
The Biology of Mutant STAT6 in Follicular Lymphoma
$356,850Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Guidelines for processing and storing liquid biopsy samples for functional assays in research and clinical testing.
$356,850Tothu Q Vu · Oregon Health & Science University · U01 · FY2025 · CA
Biology and Targeting of noncoding RNAs in AML
$356,850Ramiro Garzon · Ohio State University · R01 · FY2021 · CA